Clinical trial
OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study
NCT00134160 · OSCAR Study, Other · Completed
Key facts
| NCT number | NCT00134160 |
|---|---|
| Title | OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study |
| Official title | The Study Comparing the Incidence of Cardiovascular Events Between High-dose ARB Monotherapy and Combination Therapy With ARB and Calcium Channel Blocker in Japanese Elderly Hypertensive Patients at High Cardiovascular Risk |
| Lead sponsor | OSCAR Study, Other |
| Collaborators | Japan Heart Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Cardiovascular Diseases |
| Intervention type | Drug |
| Interventions | Olmesartan medoxomil, Calcium channel blockers (amlodipine, azelnidipine) |
| Enrollment | 1,000 |
| Start date | Aug 1, 2005 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Aug 24, 2005 |
| Last update posted | Oct 5, 2010 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: